RNA isolation for transcriptomics of human and mouse small skin biopsies by Bruning, Oskar et al.
TECHNICAL NOTE Open Access
RNA isolation for transcriptomics of human and
mouse small skin biopsies
Oskar Bruning
1, Wendy Rodenburg
2, Teodora Radonic
3, Aeilko H Zwinderman
3, Annemieke de Vries
2,
Timo M Breit
1* and Mark de Jong
1
Abstract
Background: Isolation of RNA from skin biopsies presents a challenge, due to the tough nature of skin tissue and
a high presence of RNases. As we lacked the dedicated equipment, i.e. homogenizer or bead-beater, needed for
the available RNA from skin isolation methods, we adapted and tested our zebrafish single-embryo RNA-isolation
protocol for RNA isolation from skin punch biopsies.
Findings: We tested our new RNA-isolation protocol in two experiments: a large-scale study with 97 human skin
samples, and a small study with 16 mouse skin samples. Human skin was sampled with 4.0 mm biopsy punches
and for the mouse skin different punch diameter sizes were tested; 1.0, 1.5, 2.0, and 2.5 mm. The average RNA
yield in human samples was 1.5 μg with an average RNA quality RIN value of 8.1. For the mouse biopsies, the
average RNA yield was 2.4 μg with an average RIN value of 7.5. For 96% of the human biopsies and 100% of the
mouse biopsies we obtained enough high-quality RNA. The RNA samples were successfully tested in a
transcriptomics analysis using the Affymetrix and Roche NimbleGen platforms.
Conclusions: Using our new RNA-isolation protocol, we were able to consistently isolate high-quality RNA, which
is apt for further transcriptomics analysis. Furthermore, this method is already useable on biopsy material obtained
with a punch diameter as small as 1.5 mm.
Background
The use of skin biopsies is an important method for
studying the in vivo effects of harmful agents or radiation
on skin tissue as well as skin diseases. However, for
-omics experiments such as transcriptomics, it is often
difficult to obtain sufficient RNA from biopsies. This is
primarily caused by the tough nature of skin material,
which makes it hard to homogenize a skin sample, in
addition to the high number of RNases in skin tissue that
quickly degrade the biopsy RNA [1-5]. Because of this,
several biopsies often need to be pooled, which can lead
to dilution of effects by biological variation plus various
other unwanted effects [6-8]. More or larger biopsies will
increase the discomfort for human test subjects or the
required number of test animals. More efficient ways of
isolating RNA from this limited sample material holds
the promise of decreasing the biopsy-related human dis-
comfort and numbers of test animals.
The limited amount of biopsy material from an experi-
ment of 97 human skin biopsies, i.e. half of a 4.0 mm dia-
meter biopsy, initiated the development of an optimal skin
RNA-isolation protocol. At the same time, we investigated
whether such a protocol would also allow for an experi-
mental set-up with multiple skin biopsies per mouse, as
this would imply the use of small biopsy punches (2.5 mm
- 1.0 mm). Because, neither bead-beater nor homogenizer,
which are commonly used for this type of RNA extraction
[1,2], are available in our setting, we decided to adapt our
previously described robust and highly-efficient protocol
for RNA extraction from single zebrafish embryos [9]. This
protocol is based on sample homogenization in liquid
nitrogen, RNA extraction by phenol and column purifica-
tion. By adapting the zebrafish protocol we anticipated to
be able to isolate, in an affordable way with standard equip-
ment available in most molecular biology laboratories,
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Results
After testing of several adaptations on our zebrafish single-
embryo protocol, it showed optimal performance by the
addition of a ten minutes shake step (Additional file 1,
step11) [9].
To evaluate our skin-biopsy RNA-isolation protocol,
we defined five key criteria: 1) Weight of the biopsy; 2)
RNA yield; 3) RNA Integrity Number (RIN [10]) value
for RNA quality; 4) aRNA yield after in-vitro amplifica-
tion (IVT); and 5) average probe-signal intensity level
after microarray analysis. We performed a human and a
mouse study to assess the performance of our new
RNA-isolation protocol.
For the experiment with 97 human patients, skin biop-
sies were taken with a 4.0 mm biopsy punch. Tissue mate-
rial from these biopsies was divided and one half was used
for RNA extraction, while the other half was used for
pathologic examination. The results of the five protocol-
evaluation criteria are summarized in Table 1. Applying
the Affymetrix protocol thresholds (Table 1), 100% of the
97 biopsies yielded sufficient RNA and only 4 biopsies had
a RIN value below the 6.5 threshold. Thus 96% of the
human skin biopsies displayed high enough quality for
further processing. An example of the RNA quality is
shown in Figure 1A.
To investigate the relationship between the protocol-
evaluation criteria we plotted the results of the individual
biopsies against each other (Figure 1 and Additional file 2,
3). As expected, there appears to be a linear relationship
between the weight of the starting biopsy material and the
RNA yield (Figure 1B). The RNA quality is consistently
high, however, with heavier biopsies, the spread in RNA
quality is smaller (Figure 1C). As equal amounts of input
RNA or aRNA were used in the IVT reaction and micro-
array protocol, respectively, the relation between the
biopsy weight and aRNA yield or average probe signal gets
lost. There seems to be no obvious relation between RNA
quality and aRNA yield or average probe signal (Figure 1D
and 1E).
After successful extraction of RNA from small human
skin biopsies, we tested the performance of our new
protocol in a limited experiment with mouse skin bio-
psies from test animals (un-)treated with UV light radia-
tion (Additional file 4). Here we determined the
minimal diameter size of biopsy punch that can be used
to consistently obtain sufficient RNA from a skin biopsy
for transcriptome analysis. This experiment consisted of
16 skin biopsies from four, approximately four months
old, mice, obtained by biopsy punches of different sizes
within one minute after they were euthanized. The
examined punch diameters were: 1.0, 1.5, 2.0, and
2.5 mm. As mouse skin is less firm than human skin,
we had to fold the skin while punching. For the 1.0 and
1.5 mm diameter punches the biopsies thus resulted in
two small holes (Additional file 5). For the 2.0 and
2.5 mm diameter punches a half moon shape biopsy on
folded skin was made, resulting in one round hole
(Additional file 5). Since the obtained mouse biopsies
were too small for a proper weight measurement, the
punch diameter size was used as an indicator for the
amount of material.
The results of this experiment are summarized in
Table 1. RNA from all these biopsies had a RIN value of
at least the 6.5 threshold, meaning that 100% of the
RNA samples could be used for further processing. An
example of the RNA quality is shown in Figure 2A. The
differences in scale, present between the human and
mouse studies in aRNA yield and average probe signals,
a r ec a u s e db yd i f f e r e n c e si nt h em i c r o a r r a yp l a t f o r m s
employed in the two experiments (Table 1).
To investigate our protocol-evaluation criteria, we
plotted the results for the individual biopsies (Figure 2
and Additional file 4). The relationship between the
biopsy punch diameter and RNA yield is linear (Figure
2 B ) .T h eR N Aq u a l i t yi sc o n s t a n t l yh i g h ,w i t hn oc l e a r
differences between diameter sizes, except for the 1.0
mm biopsy (Figure 1C). The resulting biopsy material
from this punch diameter size was too small for proper
and practical handling and this settled the lower punch
diameter limit to 1.5 mm. Therefore, the 1.0 mm biopsy
was left out of the microarray analysis.
Table 1 Summary of evaluation criteria for the RNA-isolation protocol
Experiment # Biopsy weight* RNA yield RIN value aRNA yield**
$ Array signal**
$¥
threshold - 0.1 μg Affymetrix
0.2 μg NimbleGen
6.5 for both platforms 10.0 μg Affymetrix
2.0 μg NimbleGen
-
avg. min. avg. min. avg. min. avg. min. avg. min.
Human 97 8.2 mg 3.2 mg 1.5 μg 0.2 μg 8.1 3.3 35.6 μg 10.0 μg 7.8 5.6
Mouse 16 ND ND 2.4 μg 0.6 μg 7.5 6.5 4.2 μg 2.9 μg 11.0 10.5
ND: not determined
* 44 half human biopsies were weighted.
** 12 mouse biopsies were analyzed by microarray technology
$ Platform dependent results and thresholds.
¥ Array averaged log2 probe intensity
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Page 4 of 8There seems to be a fairly linear relationship between
RNA quality and aRNA yield for these biopsies (Figure
2D). However, the average probe signal seems to have no
clear relation with the RNA quality (Figure 2E). For an
impression of the performance of our RNA-isolation pro-
tocol in transcriptomics, we analyzed the microarray
results by principal components analysis (PCA) (Figure 3).
The PCA result shows a clear separation of UV-treated
versus non-treated samples and an effect for test-animal.
Only the biopsy 1.5 mm sample from mouse number 4 is
relatively far away from the other samples from this
mouse on the PCA1 axis. This is most likely due to the
fact that the RNA yield is quite low compared to all other
samples (Additional file 4), which appears to have some
effect on the test-animal effect. This indicates that the dif-
ferences in biopsy punch diameter overall have a smaller
effect on gene expression than the variable “test-animal”
or experimental treatment with UV light.
Conclusions
Our RNA-isolation protocol for human and mouse
small skin biopsies presented here robustly produces
sufficient good quality RNA for transcriptomics experi-
mentation. Although our protocol results in similar
RNA yields as compared to other RNA-isolation proto-
cols [1,2] (Additional file 6), the absence for dedicated
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Figure 3 Principal components analysis of mouse microarray results. Principal components analysis (PCA) of the non-normalized log2 ratios
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on these first two principal component axis. An effect from the animal that was used, is apparent.
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Page 5 of 8laboratory equipment renders the advantage that it is
easy to implement.
Furthermore, sufficient RNA can reproducibly be
obtained by using a very small biopsy punch diameter of
just 1.5 mm. For human skin studies this may imply that
skin tissue can be obtained with significantly less discom-
fort for the test individuals. With respect to mouse
experimentation, our results indicate that animals do not
need to be sacrificed each time in vivo skin material is
needed. As such, skin biopsies up to possibly six biopsies
per animal could also be used in longitudinal studies,
requiring significantly less animals, while increasing the
statistical power by reducing the biological variation.
Methods
Biological material from humans
Skin biopsies with a 4.0 mm diameter punch were taken
from the upper thigh or upper arm of 97 patients, before
and 4 weeks after therapy with a drug to treat high blood
pressure, after local anesthesia with ethyl chloride spray.
Biopsies were immediately snap frozen in liquid nitrogen
and stored at -80°C until further processing.
The protocol has been approved by the Medical Ethical
Committee of the Academic Medical Center in Amster-
dam. The feasibility approvals have been obtained from
all the participating centers. This trial is registered in the
Netherlands Trial Register under number NTR1423.
Enrollment began in March 2008 and in October 2009
230 patients have been enrolled.
Biological material from mice
Four 3 to 4 months old SKH1 hairless mice were used in
this experiment: two were untreated controls and two
were irradiated with 300 J/m
2 UV B light. 24 hours after
exposure, both treated and untreated mice were eutha-
nized by cervical dislocation. This was followed directly
by biopsy sampling from the back to prevent RNA decay.
For one mouse, biopsies were also taken from the abdo-
men. Biopsies were immediately snap frozen in liquid
nitrogen and stored at -80°C until further processing.
Biopsies using a 1.0 mm diameter punch were
unpractical as part of the material remained inside the
skin upon punching. The 1.0 and 1.5 mm biopsies
were taken by punching through the folded skin result-
ing in two holes and the 2.0 and 2.5 mm ones by
punching a half moon shape on folded skin resulting
in one round hole.
The study was agreed upon by the institute’sE x p e r i -
mental Animal Ethical Committee and carried out in
accordance with national legislation.
RNA isolation
Per RNA isolation, one 1.5 ml tube was filled beforehand
with 75-100 mg phase-lock gel heavy (5-Prime) and
pelleted for 30 s at 12,000 × g. Single biopsies were pul-
verized to a fine powder with a standard liquid nitrogen
pre-chilled mortar and pestle. This powder was trans-
ferred to a 1.5 ml tube with 300 μl Qiazol (Qiagen). The
homogenate was vortexed vigorously for 15 s and subse-
quently shaken for 10 min on a REAX 2000 (Heidolph).
After a quick spin-down 60 μl chloroform was added to
the homogenate, vortexed for 15 s and kept at room tem-
perature for 3 min. The partly separated mixture was
transferred as a whole to a pre-prepared phase-lock gel
heavy containing tube and centrifuged for 15 min at
12,000 × g. The aqueous phase was transferred to a new
1.5 ml tube. RNA was purified by column precipitation
according to the RNeasy MinElute Cleanup Handbook
(version 2007) - Appendix D: RNA Cleanup after Lysis
and Homogenization with Qiazol Lysis Reagent (Qiagen).
At the end of the procedure, the RNA was eluted in 14 μl
nuclease-free water. A PDF file with the complete proto-
col is available in a convenient format in the Additional
file 1.
Microarrays with Human Affymetrix platform
Gene expression was analyzed with Human Exon 1.0 ST
Arrays in biopsies from all 97 patients. Sense-strand
cDNA was generated from total RNA using Ambion
WT Expression Kit (Applied Biosystems) conform the
manufacturer’s instructions. Further steps were per-
formed using the manufacturer’s protocols for the Gene-
Chip platform (Affymetrix). Those included purification
of double-stranded cDNA, synthesis of aRNA by in vitro
transcription, recovery and quantification of biotin-
labeled aRNA, fragmentation of this aRNA and subse-
quent hybridization to the microarray, post-hybridiza-
tion washings and detection of the hybridized aRNA
using a streptavidin-coupled fluorescent dye. Hybridized
Affymetrix GeneChips were scanned using a GeneChip
Scanner 3000-7G (Affymetrix). Image generation and
feature extraction were performed using Affymetrix
GCOS Software v1.4.0.036.
Microarrays with Mouse Roche NimbleGen platform
Gene expression of mouse samples was analyzed with a
12 × 135 k Mus musculus microarray (Catalog no.
05543797001, Design 090901 MM9 EXP HX12) contain-
ing 44,170 genes with 3 probes per target gene. Per
RNA sample, 200 ng total RNA was amplified according
to the Agilent LRILAK kit manual (Agilent technolo-
gies). Amino-allyl modified nucleotides were incorpo-
rated during the aRNA synthesis (2.5 mM rGAU (GE
Healthcare), 0.75 mM rCTP (GE Healthcare), 0.75 mM
AA-rCTP (TriLink Biotechnologies). Synthesized aRNA
was purified with the E.Z.N.A. MicroElute RNA Clean
Up Kit (Omega Bio-Tek). Test aRNA samples were
labeled with Cy3 and a Reference sample (made by
Bruning et al. BMC Research Notes 2011, 4:438
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Page 6 of 8pooling equimolar amounts of RNA from Test samples)
was labeled with Cy5. 5 μgo fa R N Aw a sd r i e dd o w n
and dissolved in 50 mM carbonate buffer pH 8.5. Indivi-
dual vials of Cy3/Cy5 from the mono-reactive dye packs
(GE Healthcare) were dissolved in 200 μlD M S O .T o
each sample, 10 μl of the appropriate CyDye dissolved
in DMSO was added and the mixture was incubated for
1 h. Reactions were quenched with the addition of 5 μl
4 M hydroxylamine (Sigma-Aldrich). The labeled aRNA
was purified with the E.Z.N.A. MicroElute RNA Clean
Up Kit. The yields of aRNA and CyDye incorporation
were measured on the NanoDrop ND-1000.
Each hybridization mixture was made up from 1.1 μg
Test (Cy3) and 1.1 μg Reference (Cy5) sample. Samples
were dried and 1.98 μl of water was added. The hybridi-
zation cocktail was made according to the manufacturer’s
instructions (Roche NimbleGen Arrays User’sG u i d e-
Gene Expression Arrays Version 5.0, Roche NimbleGen).
5.22 μl from this mix was added to each sample. The
samples were incubated for 5 min at 65°C and 5 min at
42°C prior to loading. Hybridization samples were loaded
onto the microarrays, and hybridized for 18 hours at
42°C with the Roche NimbleGen Hybridization System 4.
Afterwards, the slides were washed according to the
Roche NimbleGen Arrays User’sG u i d e-G e n eE x p r e s -
sion Arrays Version 5.0 and scanned in an ozone-free
room with a DNA microarray scanner G2565CA (Agilent
Technologies). Feature extraction was performed with
NimbleScan v2.5 (Roche NimbleGen). The array data
have been deposited in NCBI’s Gene Expression Omni-
bus and is accessible through GEO Series accession num-
ber GSE28463 http://www.ncbi.nlm.nih.gov/geo/.
Data analysis
To generate the average log2 probe signal for the Affyme-
trix GeneChips, raw probe intensities without control
probes were used. For the Nimblegen microarrays, raw
sample channel data without control probes was used.
Data handling, scatterplot generation and PCA analysis
were performed using R-2.11.1 http://www.R-project.org
and Bioconductor http://www.bioconductor.org/ software.
Additional material
Additional file 1: RNA isolation protocol. Step-by-step protocol
describing the isolation of RNA from skin biopsies.
Additional file 2: Human biopsies results. Table showing the quality
measure results for individual RNA samples isolated from human skin
biopsies.
Additional file 3: Scatterplots Human biopsies. Same figure as Figures
1B-E, now showing extreme outliers.
Additional file 4: Mouse biopsies results. Table showing the quality
measure results for individual RNA samples isolated from mouse skin
biopsies.
Additional file 5: Mouse biopsy sampling. Overview of resulting holes
on mouse skin after sampling with different punch diameters.
Additional file 6: Comparison to the gold standard methods. Table
showing the quality measure results of this study compared to the gold
standard methods for RNA isolation from skin biopsies.
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